abstract gray background

Accelerated GMP lab support for gene therapy program

PPD From-investigation-to-release-case-study

A biotech company faced urgent timelines for a gene therapy program and needed a partner who could move quickly without compromising quality. Through a highly collaborative approach, our GMP analytical services team delivered flexible, responsive support that helped accelerate testing and release critical patient doses on schedule.

Learn how the partnership enabled faster decision-making and consistent, high-quality results through:

Accelerated investigation-to-release timelines

Flexible support aligned to evolving program needs

High-quality GMP analytical testing at scale

Reliable delivery of critical patient doses without delay

Rapid testing to achieve truncated timeline: Read the case study